Related Experiment Video

Updated: Jun 4, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

639

Targeting protein modification: a new direction for immunotherapy of pancreatic cancer

Xinyu Ge1, Ke Zhang2, Jie Zhu1

  • 1Department of Hepatobiliary and Pancreatic Surgery, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Jiangsu 225000, China.

International Journal of Biological Sciences
|January 2, 2025
PubMed

Insights

Post-translational modifications (PTMs) are crucial for pancreatic cancer progression and immunotherapy. This study explores how PTMs impact pancreatic cancer immunotherapy, offering new research directions.

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Post-translational modifications (PTMs) regulate protein function and are vital in cellular signaling.
  • PTMs play a significant role in pancreatic cancer development, progression, and metastasis.
  • PTMs are increasingly recognized for their importance in tumor immunotherapy, affecting immune cell functions.

Purpose of the Study:

  • To investigate the impact of various post-translational modifications on pancreatic cancer immunotherapy.
  • To provide novel insights into the PTM-immunotherapy relationship in pancreatic cancer.
  • To identify future research avenues for PTM-targeted pancreatic cancer therapies.

Main Methods:

  • Literature review and analysis of existing data on PTMs in cancer.
  • Exploration of PTMs' roles in immune cell activation, trafficking, and metabolism within the tumor microenvironment.
  • Correlation analysis between specific PTMs and immunotherapy response in pancreatic cancer models.

Main Results:

  • PTMs significantly influence protein conformation and biological activity, impacting cancer signaling pathways.
  • Specific PTMs are implicated in modulating immune responses against pancreatic tumors.
  • Understanding PTMs offers potential strategies to enhance immunotherapy efficacy.

Conclusions:

  • Post-translational modifications are critical regulators in pancreatic cancer and its response to immunotherapy.
  • Targeting PTMs presents a promising avenue for improving pancreatic cancer treatment outcomes.
  • Further research into PTMs is essential for advancing pancreatic cancer immunotherapy.
Keywords:
Immune escapeImmunotherapyPancreatic cancerPost-translational modificationsTargeted therapy

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.0K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K